Arkolith/Insider Trading/VLON/Form 4

Kelly Leanne M.

Chief Financial OfficerVallon Pharmaceuticals, Inc. (VLON) · full profile →Form 4 · filed Jun 4, 2021
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 4, 2021Buy(P)2K$4.08$6K6K
Jun 3, 2021Buy(P)1K$4.05$4K5K
Jun 2, 2021Buy(P)4K$4.00$15K4K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-076998) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML